Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to AZ, Foundation Medicine Eye Targeted Cancer Therapies

    • Sequencing Assays
    • Roche
    • GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
    • Tumor Marker Control
    • Randox Laboratories
    • The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
    • BRAF Mutation Detection
    • Swift Biosciences
    • myT BRAF-Ultra, an ultrasensitive version of myT BRAF, provides 0.01% sensitivity down to single-copy detection of BRAF mutations. myT BRAF-Ultra can detect less than 10 copies of mutant BRAF V600E/K with low breakthrough amplification from a backg
    • Nitrocellulose Membranes
    • GE Healthcare Life Sciences
    • The Whatman™ FF High Performance (HP) membrane is a diagnostic membrane that enables line separation and reproducible results for the detection of target molecules in liquids such as water, urine, blood, and saliva. The target molecules may include
    • Genome Mapping System
    • BioNano Genomics
    • The Irys™ is a genome mapping system that can help genomics researchers with structural variation analysis and sequence assemblies. Irys is an automated platform that uses single-molecule imaging to visualize extremely long nucleic acids and reveal
    • Genetic Analyzer
    • Pacific Biosciences
    • The PacBio® RS high-resolution genetic analyzer has undergone a software upgrade featuring additional tools for performing DNA base modification analysis and de novo genome assembly. With the release of the SMRT Analysis 1.3.3 software upgrade
    • Microplate Detection Platform
    • Molecular Devices
    • The SpectraMax i3 platform’s base system features an integrated optical system enabling top and bottom reads for 6–384-well microplates and launches with three detection modes: luminescence, absorbance, and fluorescence. The user-exchangeable cartr
    • Knockout Cell Lines for Cancer Research
    • Cellectis bioresearch
    • The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene
    • Transfection Reagent
    • Mirus Bio
    • TransIT®-BrCa transfection reagent is a dedicated breast cancer cell-line specific reagent that can help researchers achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D. It c
    • DNA Reference Standard
    • Horizon Discovery
    • The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
    • Stabilized Pepsin
    • SciGene
    • CytoZyme™ stabilized pepsin is an advanced formulation for pretreating tissue samples in nucleic acid probe-based cytogenetic assays including FISH. CytoZyme is a ready-to-use solution of purified pepsin that can be stored in the refrigerator witho
    • Sequencing System
    • Pacific Biosciences
    • The PacBio RS II allows scientists to generate finished genome assemblies, reveal and understand epigenomes, and characterize genomic variation. Based on the SMRT sequencing technology, the RS II can generate average read lengths of 5,000 base pair
  • Page 1 of 1 (13 items) 1 

GEN Poll

More » Poll Results » Archive »

Myriad Genetics Trial: Your Thoughts?

Do you agree with the Supreme Court’s decision in the Myriad case?

Suggest a Poll